Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Video Abstracts
Reviews
Reviews
View all reviews ...
Review Series
Microbiome in Health and Disease (Feb 2025)
Substance Use Disorders (Oct 2024)
Clonal Hematopoiesis (Oct 2024)
Sex Differences in Medicine (Sep 2024)
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
Levon M. Khachigian
Levon M. Khachigian
Published November 15, 2000
Citation Information:
J Clin Invest.
2000;
106(10)
:1189-1195.
https://doi.org/10.1172/JCI11620
.
View:
Text
|
PDF
Perspective
Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
Text
PDF
Abstract
Authors
Levon M. Khachigian
×
Options:
View larger image
(or click on image)
Download as PowerPoint
DNAzymes as inhibitors of gene expression